CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE

Provided are several crystalline forms of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl) amino)-N-(methyl-d3)pyridazine-3-carboxamide: Form F, Form G, Form H, Form I, Form J, and Form K. Certain of these crystalline forms are hydrates. Characterization data for e...

Full description

Saved in:
Bibliographic Details
Main Authors YATES, Ian, PEARSON, David James, KELK, Natalie Louise, LEMBKE, Franz, ROBERTS, Daniel Richard, CHOI, Candice Y, DABROS, Marta, WEI, Chenkou
Format Patent
LanguageEnglish
French
Published 06.10.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided are several crystalline forms of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl) amino)-N-(methyl-d3)pyridazine-3-carboxamide: Form F, Form G, Form H, Form I, Form J, and Form K. Certain of these crystalline forms are hydrates. Characterization data for each of these crystalline forms are provided. L'invention concerne plusieurs formes cristallines de 6-(cyclopropaneamido)-4-((2-méthoxy-3-(1-méthyl-1H-1,2,4-triazol-3-yl)phényl)amino)-N-(méthyl-d3)pyridazine-3-carboxamide : la forme F, la forme G, la forme H, la forme I, la forme J et la forme K. Certaines de ces formes cristallines sont des hydrates. L'invention concerne également des données de caractérisation pour chacune de ces formes cristallines.
Bibliography:Application Number: WO2022US21815